Literature DB >> 29848056

Urinary tract infection attributed to Escherichia coli isolated from participants attending an unorganized gathering.

Kamelia M Osman1, Anthony D Kappell2, Fatma ElHofy3, Ahmed Orabi1, Ayman S Mubarak4, Turki M Dawoud4, Ihab Mi Moussa4, Ashgan M Hessain5.   

Abstract

AIM: Participants in an unorganized gathering are potential hosts of diseases, bringing diseases from around the world to be introduced to a large at-risk population. Therefore, we investigated the gene repertoire in 29 Escherichia coli strains linked to urinary tract infection isolated from patients transferred to the hospital after attending an unorganized gathering in Cairo. MATERIALS &
METHODS: Virulence and resistance determinants, phenotypic antibiotic resistance, biofilm formation, their serotypes and phylogenetic relationships were analyzed.
RESULTS: The 29 tested serovars were phenotypically virulent, with the prevalence of group B2, and resistant to tetracycline, naldixic acid, ampicillin, trimethoprim, neomycin, oxytetracycline and erythromycin encoding the iss virulent gene.
CONCLUSION: A One Health approach is a must to monitor and control E. coli urinary tract infections.

Entities:  

Keywords:  Egypt; Escherichia coli; UTI; antibiotic resistance genes; biofilm; virulence genes

Mesh:

Substances:

Year:  2018        PMID: 29848056     DOI: 10.2217/fmb-2017-0304

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  2 in total

1.  Phylogenetic group determination and plasmid virulence gene profiles of colistin-resistant Escherichia coli originated from the broiler meat supply chain in Bogor, Indonesia.

Authors:  Irma Rahayuningtyas; Agustin Indrawati; I Wayan Teguh Wibawan; Maria Fatima Palupi; Istiyaningsih Istiyaningsih
Journal:  Vet World       Date:  2020-09-05

2.  YbdO Promotes the Pathogenicity of Escherichia coli K1 by Regulating Capsule Synthesis.

Authors:  Yu Fan; Hongmin Sun; Wen Yang; Jing Bai; Peng Liu; Min Huang; Xi Guo; Bin Yang; Lu Feng
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.